The EGFR/ErbB3 pathway acts as a compensatory survival mechanism upon c-Met inhibition in human c-Met+ hepatocellular carcinoma

Steven N. Steinway, Hien Dang, Hanning You, C. Bart Rountree, Wei Ding

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'The EGFR/ErbB3 pathway acts as a compensatory survival mechanism upon c-Met inhibition in human c-Met+ hepatocellular carcinoma'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences

Agriculture & Biology